Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature
- 17 June 2004
- journal article
- review article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 130 (9), 497-513
- https://doi.org/10.1007/s00432-004-0572-9
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Detection and Prediction of Micrometastasis in the Lymph Nodes of Patients With pN0 Gastric CancerAnnals of Surgical Oncology, 2001
- A comparative study of the clinicopathological significance of E-cadherin and catenins (α, β, γ) expression in the surgical management of oral tongue carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2001
- RECK gene expression in hepatocellular carcinoma: Correlation with invasion-related clinicopathological factors and its clinical significanceHepatology, 2001
- Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinomaThe Journal of Pathology, 2000
- Altered expression of E-cadherin in breast cancerEuropean Journal Of Cancer, 2000
- The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinomaCancer, 2000
- Reduced E-Cadherin Expression and Enlargement of Cancer Nuclei Strongly Correlate with Hematogenic Metastasis in Colorectal AdenocarcinomaScandinavian Journal of Gastroenterology, 2000
- TP53Mutation is an Independent Prognostic Marker for Poor Outcome in Both Node-negative and Node-positive Breast CancerActa Oncologica, 2000
- Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinomaBritish Journal of Surgery, 1999
- Presence of α-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinomaJournal of Hepatology, 1999